AbbVie's Rinvoq (upadacitinib) Receives EC's Approval for the Treatment of Adults with Ulcerative Colitis
July 27, 2022
Sandoz Reports the EMA Acceptance of Hyrimoz (biosimilar, adalimumab) Application
June 17, 2022
Everest Licensing Partner Pfizer Presents Results of Etrasimod in P-III (ELEVATE UC 12 & 52) Studies for the Treatment of Ulcerati...
May 25, 2022
Lilly Reports Clinical Remission in 50% of Patients Treated with Mirikizumab in P-III (LUCENT-2) Trial for the Treatment of Ulcera...
May 24, 2022
Protagonist Reports Results of PN-943 in P-II (IDEAL) Study for the Treatment of Ulcerative Colitis
April 27, 2022
Gilead, Eisai and EA Pharma’s Jyseleca (filgotinib) Receive the MHLW’s Approval for the Treatment of Ulcerative Colitis
March 28, 2022
No more records!
Incisive News in 3 Shots.
First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2022 PharmaShots - All Rights Reserved.